290 related articles for article (PubMed ID: 22058034)
41. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
[TBL] [Abstract][Full Text] [Related]
42. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.
Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H
J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419
[TBL] [Abstract][Full Text] [Related]
43. Direct Reprogramming, Epigenetics, and Cardiac Regeneration.
Kurotsu S; Suzuki T; Ieda M
J Card Fail; 2017 Jul; 23(7):552-557. PubMed ID: 28529134
[TBL] [Abstract][Full Text] [Related]
44. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
Hsu YC; Wu YT; Tsai CL; Wei YH
Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
[TBL] [Abstract][Full Text] [Related]
45. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
46. Transactivator protein: An alternative for delivery of recombinant proteins for safer reprogramming of induced Pluripotent Stem Cell.
Nordin F; Ahmad RNR; Farzaneh F
Virus Res; 2017 May; 235():106-114. PubMed ID: 28408207
[TBL] [Abstract][Full Text] [Related]
47. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
[TBL] [Abstract][Full Text] [Related]
48. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
Liu C; Ameen M; Himmati S; Thomas D; Sayed N
Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
[TBL] [Abstract][Full Text] [Related]
49. Induced pluripotent stem (iPS) cells from human fetal stem cells.
Guillot PV
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
[TBL] [Abstract][Full Text] [Related]
50. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
Wang AYL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
[TBL] [Abstract][Full Text] [Related]
51. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
[TBL] [Abstract][Full Text] [Related]
52. Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
Dhanjal DS; Singh R; Sharma V; Nepovimova E; Adam V; Kuca K; Chopra C
Curr Med Chem; 2024; 31(13):1646-1690. PubMed ID: 37138422
[TBL] [Abstract][Full Text] [Related]
53. Selected small molecules as inducers of pluripotency.
Baranek M; Markiewicz WT; Barciszewski J
Acta Biochim Pol; 2016; 63(4):709-716. PubMed ID: 27785481
[TBL] [Abstract][Full Text] [Related]
54. Generation of human-induced pluripotent stem cells (hiPSCs) using episomal vectors on defined Essential 8™ Medium conditions.
Fontes A; Macarthur CC; Lieu PT; Vemuri MC
Methods Mol Biol; 2013; 997():57-72. PubMed ID: 23546748
[TBL] [Abstract][Full Text] [Related]
55. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
56. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
57. Induced pluripotent stem cells' self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium.
Solari C; Losino N; Luzzani C; Waisman A; Bluguermann C; Questa M; Sevlever G; Miriuka S; Barañao L; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(2):252-7. PubMed ID: 21651896
[TBL] [Abstract][Full Text] [Related]
58. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
59. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
Lewandowski J; Kurpisz M
Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
[TBL] [Abstract][Full Text] [Related]
60. Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality.
Cao S; Loh K; Pei Y; Zhang W; Han J
Protein Cell; 2012 Nov; 3(11):834-45. PubMed ID: 23073833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]